Published in Cancer Prev Res (Phila) on December 12, 2011
Burden of cancer in Malawi; common types, incidence and trends: national population-based cancer registry. BMC Res Notes (2012) 2.88
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One (2013) 1.37
Notes from the field: "green" chemoprevention as frugal medicine. Cancer Prev Res (Phila) (2012) 1.11
Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr (2014) 1.01
Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr (2014) 0.99
Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One (2015) 0.97
Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries. PLoS One (2015) 0.91
Global HIV epidemiology: A guide for strategies in prevention and care. Curr HIV/AIDS Rep (2014) 0.85
Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Int J Gynaecol Obstet (2014) 0.83
Major challenges to scale up of visual inspection-based cervical cancer prevention programs: the experience of Guatemalan NGOs. Glob Health Sci Pract (2014) 0.82
Cervical cancer: Can it be prevented? World J Clin Oncol (2014) 0.82
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health (2016) 0.81
Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up. Oncologist (2015) 0.81
The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer (2015) 0.80
Beliefs, perceptions and health-seeking behaviours in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign. Glob Health Action (2016) 0.78
Evaluation of the accuracy in detecting cervical lesions by nurses versus doctors using a stationary colposcope and Gynocular in a low-resource setting. BMJ Open (2014) 0.78
Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer. Int J Clin Exp Pathol (2014) 0.77
Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples. J Infect Dis (2015) 0.76
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. J Natl Cancer Inst (2012) 0.76
A systematic review of primary care models for non-communicable disease interventions in Sub-Saharan Africa. BMC Fam Pract (2017) 0.75
The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study. Cancer Causes Control (2016) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
HPV screening for cervical cancer in rural India. N Engl J Med (2009) 14.13
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet (2007) 6.77
Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med (2005) 6.72
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis (2009) 5.01
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine (2008) 4.82
Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst (2011) 4.59
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol (2008) 4.43
Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ (2001) 4.28
Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med (2008) 3.02
Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep (2011) 2.72
Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol (2011) 2.52
Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS (2009) 2.42
The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol (2009) 2.39
Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer (2007) 2.36
Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med (2011) 2.28
Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol (2008) 2.22
Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet (2011) 2.01
Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis (2007) 2.00
eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis (2010) 1.98
Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine (2006) 1.86
The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels. Cancer Prev Res (Phila) (2011) 1.85
Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol (2011) 1.85
Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer (2007) 1.76
Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J Natl Cancer Inst (2011) 1.71
Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer (2011) 1.53
HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol (2009) 1.48
Preventing cervical cancer globally by acting locally: if not now, when? J Natl Cancer Inst (2010) 1.46
Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) (2012) 1.46
Preventing HIV transmission in married and cohabiting HIV-discordant couples in sub-Saharan Africa through combination prevention. Curr HIV Res (2010) 1.42
Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ (2005) 1.35
The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer (2010) 1.32
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer (2008) 1.30
Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer (2011) 1.29
The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. Arch Pathol Lab Med (1997) 1.19
HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS (2009) 1.18
Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol (2002) 1.11
Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women. J Infect Dis (2010) 1.10
Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr (2006) 1.09
Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3. AIDS (2011) 1.08
Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization. Sex Transm Dis (2006) 1.07
Can visual cervical screening be sustained in routine health services? Experience from Mali, Africa. BJOG (2011) 1.05
Preventing cancer with vaccines: progress in the global control of cancer. Cancer Prev Res (Phila) (2012) 1.00
High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers. Infect Dis Obstet Gynecol (2011) 0.96
Infection and cervical neoplasia: facts and fiction. Int J Clin Exp Pathol (2008) 0.94
Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther (2010) 0.94
Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. BMC Med (2010) 0.93
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study. Gynecol Oncol (2009) 0.92
Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. J Acquir Immune Defic Syndr (2007) 0.91
Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country. Int J Cancer (2011) 0.91
Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda. Reprod Health (2010) 0.90
Human papillomavirus vaccines versus cervical cancer screening. Clin Oncol (R Coll Radiol) (2008) 0.90
Program spending to increase adherence: South African cervical cancer screening. PLoS One (2009) 0.89
Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy. J Virol (2010) 0.88
Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. J Infect Dis (2011) 0.87
HPV vaccination to prevent HIV infection: time for randomized controlled trials. Sex Transm Dis (2011) 0.85
HIV epidemiology, testing strategies, and prevention interventions. Top HIV Med (2010) 0.81
Aspirin and familial adenomatous polyposis: coming full circle. Cancer Prev Res (Phila) (2011) 0.80
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions. Antiviral Res (2011) 0.80
A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. J Virol Methods (2011) 0.79
Screening for cervical cancer: which common technique is the most cost-effective choice? Asian Pac J Cancer Prev (2009) 0.78
Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS (2003) 4.82
Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol (2006) 3.68
Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS (2005) 2.97
Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J Acquir Immune Defic Syndr (2003) 2.97
Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol (2008) 2.96
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS (2008) 2.91
Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep (2011) 2.72
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. J Infect Dis (2005) 2.47
Physician emigration from sub-Saharan Africa to the United States: analysis of the 2011 AMA physician masterfile. PLoS Med (2013) 2.47
Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS (2009) 2.42
Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambézia, Mozambique. J Acquir Immune Defic Syndr (2011) 2.39
Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS (2006) 2.36
Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis (2005) 2.32
Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med (2011) 2.28
Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol (2008) 2.22
Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS (2007) 2.19
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol (2007) 2.17
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis (2008) 2.13
eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis (2010) 1.98
Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88
Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses (2008) 1.84
Training programmes in global health. BMJ (2010) 1.83
An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol (2010) 1.81
Nurturing the global workforce in clinical research: the National Institutes of Health Fogarty International Clinical Scholars and Fellows Program. Am J Trop Med Hyg (2011) 1.81
Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr (2008) 1.73
Vaginal douching: evidence for risks or benefits to women's health. Epidemiol Rev (2002) 1.71
High prevalence of HIV and syphilis in a remote native community of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.70
Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr (2011) 1.68
Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven provinces in China with historically low HIV prevalence. J Acquir Immune Defic Syndr (2010) 1.65
Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique. BMC Int Health Hum Rights (2010) 1.64
Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa. BMJ (2007) 1.63
Educational programs to enhance medical expertise in tropical diseases: the Gorgas Course experience 1996-2001. Am J Trop Med Hyg (2002) 1.60
Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med (2006) 1.58
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health (2002) 1.56
Risk factors for syphilis and prevalence of HIV, hepatitis B and C among men who have sex with men in Beijing, China: implications for HIV prevention. AIDS Behav (2008) 1.55
Use of traditional medicine among pregnant women in Lusaka, Zambia. J Altern Complement Med (2007) 1.55
HIV voluntary counseling and testing among injection drug users in south China: a study of a non-government organization based program. AIDS Behav (2007) 1.55
Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care (2006) 1.52
Partner notification for sexually transmitted infections in developing countries: a systematic review. BMC Public Health (2010) 1.42
Prevalence of HIV infection and predictors for syphilis infection among female sex workers in southern China. Southeast Asian J Trop Med Public Health (2009) 1.42
A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol (2003) 1.41
Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis (2005) 1.37
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One (2013) 1.37
Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol (2008) 1.35
Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia. BMC Infect Dis (2009) 1.35
Training programs within global networks: lessons learned in the Fogarty International Clinical Research Scholars and Fellows Program. Am J Trop Med Hyg (2013) 1.33
Recruiting trainees for a global health research workforce: the National Institutes of Health Fogarty International Clinical Research Scholars Program selection process. Am J Trop Med Hyg (2013) 1.33
CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J Infect Dis (2003) 1.29
Do targeted HIV programs improve overall care for pregnant women?: Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs. J Acquir Immune Defic Syndr (2008) 1.29
Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer (2011) 1.29
Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health (2011) 1.28
Willingness to be circumcised for preventing HIV among Chinese men who have sex with men. AIDS Patient Care STDS (2009) 1.28
Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res (2002) 1.27
Factors associated with HIV testing among HIV-positive and HIV-negative high-risk adolescents: the REACH Study. Reaching for Excellence in Adolescent Care and Health. Pediatrics (2002) 1.26
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS (2002) 1.24
Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health (2010) 1.23
HIV, Hepatitis B, and Hepatitis C in Zambia. J Glob Infect Dis (2011) 1.22
Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS (2004) 1.22
An intervention to reduce vaginal douching among adolescent and young adult women: a randomized, controlled trial. Sex Transm Dis (2005) 1.21
Sources of data for improved surveillance of HIV/AIDS in China. Southeast Asian J Trop Med Public Health (2007) 1.20
Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS (2003) 1.20
HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings. J Acquir Immune Defic Syndr (2014) 1.17
Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots. J Clin Microbiol (2007) 1.16
Increasing AIDS case reports in the South: U.S. trends from 1981-2004. AIDS Care (2006) 1.15
Bisexual behavior and infection with HIV and syphilis among men who have sex with men along the east coast of China. AIDS Patient Care STDS (2011) 1.14
HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial. Sex Transm Dis (2009) 1.13
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sex Transm Dis (2006) 1.13
The association among literacy, numeracy, HIV knowledge and health-seeking behavior: a population-based survey of women in rural Mozambique. PLoS One (2012) 1.13
Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes. Harm Reduct J (2008) 1.12
Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique. Am J Epidemiol (2013) 1.11
Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. AIDS (2013) 1.11
Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique. J Acquir Immune Defic Syndr (2012) 1.11
Anal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr (2013) 1.10
Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province. J Int AIDS Soc (2012) 1.10
Randomized controlled trial to improve childhood immunization adherence in rural Pakistan: redesigned immunization card and maternal education. Trop Med Int Health (2010) 1.09
Predictors of HIV testing among men who have sex with men in a large Chinese city. Sex Transm Dis (2013) 1.08
Health literacy predicts pediatric dosing accuracy for liquid zidovudine. AIDS (2014) 1.08
Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS (2004) 1.07
'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med (2012) 1.07
Determinants of third dose of diphtheria-tetanus-pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study. Trop Med Int Health (2009) 1.06
Pulmonary tuberculosis in mumbai, India: factors responsible for patient and treatment delays. Int J Prev Med (2012) 1.06
Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol (2007) 1.06
HIV prevention in women: next steps. Science (2011) 1.04
Parents'/guardians' willingness to vaccinate their children against genital herpes. J Adolesc Health (2005) 1.04
Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ (2008) 1.04
Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. J Acquir Immune Defic Syndr (2014) 1.04
HIV knowledge and health-seeking behavior in Zambézia Province, Mozambique. SAHARA J (2012) 1.04
Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project. Arch Pediatr Adolesc Med (2009) 1.03
Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One (2010) 1.03
Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr (2004) 1.03